C O M M U N I C A T I O N S
Table 2. Cross-Coupling of Aryl Sulfamatesa
Figure 2. Synthesis of flurbiprofen using orthogonal cross-couplings.
technology presented herein allows for the installation of multiple
functional groups onto an aromatic ring prior to the cross-coupling
event, as demonstrated by a concise synthesis of the anti-
inflammatory drug flurbiprofen.
Acknowledgment. The authors are grateful to the NIH-NIGMS
(R00 GM079922), the University of California, Los Angeles, the
Amgen Scholars Program (undergraduate fellowship to M.R.), and
Boehringer Ingelheim for financial support. We thank Takeru
Furuya (Harvard University), Professor Ritter (Harvard University),
and Professor Snieckus (Queen’s University) for pertinent discus-
sions, the Garcia-Garibay laboratory (UCLA) for access to instru-
mentation, and Dr. John Greaves (UC Irvine) for mass spectra.
Supporting Information Available: Detailed experimental proce-
dures and compound characterization data. This material is available
References
(1) (a) Metal-Catalyzed Cross-Coupling Reactions; Diederich, F., Meijere, A.,
Eds.; Wiley-VCH: Weinheim, Germany, 2004. (b) Hassan, J.; Se´vignon,
M.; Gozzi, C.; Schulz, E.; Lemaire, M. Chem. ReV. 2002, 102, 1359. (c)
Cross-Coupling Reactions: A Practical Guide; Miyaura, N., Ed.; Topics
in Current Chemistry, Vol. 219; Springer-Verlag: Berlin, 2002. (d) Corbet,
J.; Mignani, G. Chem. ReV. 2006, 106, 2651. (e) Negishi, E. Bull. Chem.
Soc. Jpn. 2007, 80, 233.
(2) Tobisu, M.; Shimasaki, T.; Chatani, N. Angew. Chem., Int. Ed. 2008, 47, 4866.
(3) For reviews, see: (a) Tobisu, M.; Chatani, N. Angew. Chem., Int. Ed. 2009,
48, 3565. (b) Goossen, L. J.; Goossen, K.; Stanciu, C. Angew. Chem., Int.
Ed. 2009, 48, 3569. (c) Knochel, P.; Gavryushin, A. Synfacts 2009, 200.
(4) (a) Quasdorf, K. W.; Tian, X.; Garg, N. K. J. Am. Chem. Soc. 2008, 130,
14422. (b) Guan, B.-T.; Wang, Y.; Li, B.-J.; Yu, D.-G.; Shi, Z.-J. J. Am.
Chem. Soc. 2008, 130, 14468.
(5) The ortho-directing ability of methyl ethers is modest (see ref 7a and
references therein), whereas ortho substitution of aryl pivalates presents a
considerable challenge.
(6) For pertinent reviews, see: (a) Richy, F.; Rabehnda, V.; Mawet, A.;
Reginster, J.-Y. Int. J. Clin. Pract. 2007, 61, 1396. (b) Kumar, P.; Pathak,
P. K.; Gupta, V. K.; Srivastava, B. K.; Kushwaha, B. S. Asian J. Chem.
2004, 16, 558.
(7) (a) For a review, see: Snieckus, V. Chem. ReV. 1990, 90, 879. (b) For the
use of sulfamates in directed metallation reactions and Kumada couplings,
see: Macklin, T. K.; Snieckus, V. Org. Lett. 2005, 7, 2519.
a Conditions: NiCl2(PCy3)2 (5 mol %), ArB(OH)2 (2.5 equiv), K3PO4
(4.5 equiv), toluene (0.3 M), 110 °C, 24 h. b Isolated yields. c Conditions:
NiCl2(PCy3)2 (10 mol %), ArB(OH)2 (4 equiv), K3PO4 (7.2 equiv),
toluene (0.3 M), 130 °C, 24 h.
alization of phenyl dimethylsulfamate,12 underwent smooth cross-
coupling in excellent yields (entries 14-17).
To further probe the scope and utility of the sulfamate cross-coupling
methodology, a synthesis of the anti-inflammatory drug flurbiprofen6 was
performed (Figure 2). Boronic acid 3, derived from ortho lithiation/
borylation of phenyl dimethylsulfamate,12 was fluorinated using the
conditions described by Furuya and Ritter13 to provide fluorosulfamate
4. Selective iodination of 4 para to the sulfamate furnished 5 in 64% yield.
Notably, both the fluoride and sulfamate of 5 were deemed unreactive
toward Pd(0). As the aryl iodide displayed orthogonal reactivity, we carried
out a site-selective enolate coupling to install the necessary propionate
side chain. Whereas enolate coupling of aryl iodide 5 under Buchwald’s
Pd-based conditions was feasible,14 higher yields of 6 were obtained using
a Ni-catalyzed variant.15 Although the sulfamate was not disturbed in this
process, exposure of 6 to our Ni-catalyzed Suzuki-Miyaura conditions
facilitated the key sulfamate cross-coupling. Acid-mediated hydrolysis
furnished flurbiprofen (1) in 84% yield over the two steps. It should be
emphasized that the aryl fluoride of 6 was chemically inert under our Ni-
catalyzed cross-coupling conditions.16
(8) Arenes that possess an -OC(O)R substituent are well-known to undergo
electrophilic aromatic substitution to predominantly afford para-substituted
products. See: Smith, M. B.; March, J. March’s AdVanced Organic
Chemistry, 6th ed.; Wiley: Hoboken, NJ, 2007; p 668.
(9) (a) Sengupta, S.; Leite, M.; Raslan, D. S.; Quesnelle, C.; Snieckus, V. J. Org.
Chem. 1992, 57, 4066. (b) Dallaire, C.; Kolber, I.; Gingras, M. Org. Synth.
2002, 78, 42. (c) Yoshikai, N.; Matsuda, H.; Nakamura, E. J. Am. Chem. Soc.
2009, 131, 9590. (d) Wehn, P. M.; Du Bois, J. Org. Lett. 2005, 7, 4685.
(10) NiCl2(PCy3)2 is now commercially available from Strem Chemicals Inc.
(cat. no. 28-0091) and can be prepared in multigram quantities following
a simple one-step protocol. See: (a) Stone, P. J.; Dori, Z. Inorg. Chim.
Acta 1971, 5, 434. (b) Barnett, K. W. J. Chem. Educ. 1974, 51, 422.
(11) In the presence of excess arylboronic acid, NiCl2(PCy3)2 is thought to
undergo reduction to an active Ni(0) catalyst.
(12) See the Supporting Information for details.
(13) Furuya, T.; Ritter, T. Org. Lett. 2009, 11, 2860.
(14) Moradi, W. A.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 7996.
(15) Durandetti, M.; Gosmini, C.; Pe´richon, J. Tetrahedron 2007, 63, 1146.
(16) For Ni-catalyzed Kumada and Suzuki-Miyaura couplings of aryl fluorides,
see: (a) Yoshikai, N.; Mashima, H.; Nakamura, E. J. Am. Chem. Soc. 2005,
127, 17978. (b) Dankwardt, J. W. J. Organomet. Chem. 2005, 690, 932.
(c) Schaub, T.; Backes, M.; Radius, U. J. Am. Chem. Soc. 2006, 128, 15964.
In summary, we have discovered the first Suzuki-Miyaura
coupling reactions of aryl carbamates, carbonates, and sulfamates.
The method relies on the use of a readily available, air-stable Ni(II)
complex to facilitate the desired transformations. Furthermore, the
JA906477R
9
J. AM. CHEM. SOC. VOL. 131, NO. 49, 2009 17749